{"filings":[{"id":93744,"accession_number":"0001570562-26-000064","cik":1570562,"company_name":"Evolus, Inc.","ticker":"EOLS","form_type":"8-K","filed_at":"2026-05-04T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Evolus Q1 2026 rev $73.1M (+7% YoY); Adjusted EBITDA positive $0.6M","event_type":"earnings","confidence":"high","bullets":["Global net revenue $73.1M (+7% vs Q1 2025); GAAP operating loss narrowed to $6.8M from $15.2M.","Second consecutive quarter of positive Adj EBITDA ($0.6M) vs ($5.5M) loss in Q1 2025.","Reaffirmed FY2026 net revenue guidance $327M-$337M (10-13% growth) and low- to mid-single digit Adj EBITDA margin.","Cash $49.8M at quarter end; terminated $50M ATM with no shares sold; ~$120M additional capacity noted.","Potential 15% tariff on Jeuveau from Sep 29, 2026; company says it has flexibility to mitigate near-term impact."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":73137000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105617,"accession_number":"0001570562-26-000043","cik":1570562,"company_name":"Evolus, Inc.","ticker":"EOLS","form_type":"8-K","filed_at":"2026-03-13T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Evolus reclassifies Vikram Malik to Class II director after board refresh","event_type":"other","confidence":"high","bullets":["Simone Blank stepped down from the Board to support refreshment efforts, causing class imbalance.","Vikram Malik resigned as Class III director and was immediately appointed as Class II director.","Board now has six directors, with two in each class (Class I, II, III).","Malik continues as Chairman and Compensation Committee member; no new equity award granted.","Reclassification effective March 13, 2026; Malik's service was continuous and uninterrupted."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105616,"accession_number":"0001628280-26-013872","cik":1570562,"company_name":"Evolus, Inc.","ticker":"EOLS","form_type":"8-K","filed_at":"2026-03-03T23:59:59+00:00","items":["1.01","2.02","2.03","9.01"],"status":"ready","headline":"Evolus Q4 GAAP operating income $4.2M; FY25 revenue $297.2M up 12%; guides 2026 rev $327-337M","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP operating income $4.2M vs loss $2.3M YoY; Non-GAAP operating income $7.1M, above guidance.","Full-year 2025 revenue $297.2M, up 12% YoY; sixth consecutive year of double-digit growth.","2026 revenue guidance $327M-$337M (10-13% growth); expects low- to mid-single-digit adjusted EBITDA margin.","Entered $30M secured revolving credit facility with Eclipse Business Capital (SOFR+4.25%, matures March 2029).","Evolysse (device from France) subject to 10% tariff; evaluating recovery; Jeuveau not impacted by tariffs."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105615,"accession_number":"0001570562-26-000003","cik":1570562,"company_name":"Evolus, Inc.","ticker":"EOLS","form_type":"8-K","filed_at":"2026-01-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Evolus Q4 2025 prelim rev $88.6-90.6M (+12-15%); 2026 rev guide $327-337M; targets profitability","event_type":"earnings","confidence":"high","bullets":["Preliminary Q4 2025 net revenue $88.6M-$90.6M, 12-15% YoY growth; positive non-GAAP op income $5M-$7M.","FY 2025 net revenue $295.5M-$297.5M, 11-12% YoY; Evolysse HA gels contributed ~8% of total revenue.","2026 guidance: net revenue $327M-$337M (11-13% growth); sustainable annual profitability commencing in 2026.","Updated 2028 long-term outlook: net revenue $450M-$500M (15-19% CAGR); non-GAAP op margin 13-15%.","Cash $53M at Dec 31, 2025, up from $43.5M at Sep 30, 2025, reflecting strong sales and expense management."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.8,"consensus_revenue_estimate":null,"consensus_revenue_actual":297176000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121900,"accession_number":"0001628280-25-049564","cik":1570562,"company_name":"Evolus, Inc.","ticker":"EOLS","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Evolus Q3 revenue $69M (+13% YoY); expects Q4 non-GAAP operating profit $5-7M","event_type":"earnings","confidence":"high","bullets":["Q3 total net revenue $69.0M, up 13% YoY; global Jeuveau $63.2M, Evolysse $5.7M.","GAAP operating loss $11.5M; non-GAAP operating loss $3.1M, improved from $6.7M in Q3 2024.","Now expects positive non-GAAP operating income of $5M-$7M in Q4 2025 and sustainable annual profitability from 2026.","Reaffirms FY2025 revenue guidance $295M-$305M and non-GAAP OpEx $208M-$213M.","Evolysse launch with $5.7M revenue described as strongest HA filler debut in over a decade."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.8,"consensus_revenue_estimate":null,"consensus_revenue_actual":206876000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138590,"accession_number":"0001570562-25-000110","cik":1570562,"company_name":"Evolus, Inc.","ticker":"EOLS","form_type":"8-K","filed_at":"2025-09-08T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Evolus appoints Tatjana Mitchell as CFO effective Sept 8, 2025","event_type":"leadership","confidence":"high","bullets":["Appointed Tatjana Mitchell as CFO; previously SVP Finance at Experian, CFO of Experian Consumer Services.","Base salary $490K; signing bonus $100K (subject to clawback); target annual bonus 55% of base.","Received inducement equity: option and RSUs each valued at $750K; option vests over 4 years, RSUs over 3-4 years.","Severance: 12 months base + prorated bonus (non-cause); 18 months base + full target bonus + equity acceleration (change-in-control)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138589,"accession_number":"0001570562-25-000094","cik":1570562,"company_name":"Evolus, Inc.","ticker":"EOLS","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Evolus Q2 revenue $69.4M (+4% YoY); cuts FY2025 guidance to $295-305M; CEO appointed PFO, CMO departing","event_type":"earnings","confidence":"high","bullets":["Q2 net revenue $69.4M, up 4% YoY; GAAP op loss $10.2M vs $7.7M loss YoY; non-GAAP op loss $7.9M vs $1.1M income.","FY2025 revenue guidance reset to $295-305M (11-15% growth); non-GAAP op expenses $208-213M with $25M savings.","Evolysse filler delivered $9.7M revenue in Q2, strongest filler launch quarter in over a decade.","CEO David Moatazedi appointed as Principal Financial Officer; CMO Tomoko Yamagishi-Dressler departing Aug 22, no disagreement.","Expects meaningful profitability in Q4 2025 and annual profitability from 2026; 15% Evolysse tariff minimal impact."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.56,"consensus_revenue_estimate":null,"consensus_revenue_actual":137909000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":156042,"accession_number":"0001570562-25-000085","cik":1570562,"company_name":"Evolus, Inc.","ticker":"EOLS","form_type":"8-K","filed_at":"2025-06-06T23:59:59+00:00","items":["5.02","5.07"],"status":"ready","headline":"Evolus annual meeting elects directors; Director Blank departs in planned transition","event_type":"other","confidence":"high","bullets":["Simone Blank stepped down from board effective June 5, 2025, as part of planned refreshment; no disagreement.","Stockholders elected David Gill (31.5M for) and Albert White III (36.8M for) as Class I directors until 2028.","Ratification of Ernst & Young as auditor for 2025: 48.35M for, 0.19M against, 7K abstain.","Advisory vote on named executive officer compensation passed: 35.68M for, 1.23M against, 11.44M broker non-votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":156041,"accession_number":"0001570562-25-000083","cik":1570562,"company_name":"Evolus, Inc.","ticker":"EOLS","form_type":"8-K","filed_at":"2025-05-27T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Evolus CFO Sandra Beaver resigns effective June 13, 2025, to join private mental health tech company","event_type":"leadership","confidence":"high","bullets":["Sandra Beaver resigns as CFO effective June 13, 2025; no disagreement with the company on operations or accounting.","Beaver leaves to become CFO at a private mental health and wellness technology company.","Company has initiated a search for successor; experienced finance team to lead interim.","CEO cites strong momentum: recent second product launch, record revenues, solid balance sheet, path to profitability."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}